Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib

doi:10.4254/wjh.v2.i6.239

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 2, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2679)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

318

HTML

2218

Figures (1-2)

143

Sum=2679

Jun 27, 2010 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Hepatol. Jun 27, 2010; 2(6): 239-242
Published online Jun 27, 2010. doi: 10.4254/wjh.v2.i6.239

Full Size Figure Download Figure

Figure 1 Computed tomography (CT)-scans: Axial IV contrast enhanced CT. Arterial phase image showing the reference lesion at the indicated time points. Size of this lesion remained stable between 2007 and 2009. A: CT liver November, 2007; B: CT liver December, 2009.

Citation: Roderburg C, Bubenzer J, Spannbauer M, O ND, Mahnken A, Ludde T, Trautwein C, Tischendorf JJ. Long-term survival of a HCC-patient with severe liver dysfunction treated with sorafenib. World J Hepatol 2010; 2(6): 239-242
URL: https://www.wjgnet.com/1948-5182/full/v2/i6/239.htm
DOI: https://dx.doi.org/10.4254/wjh.v2.i6.239